Search Results for:Ari Altstedter

India: Carlyle-backed diagnostic chain Metropolis considers $230m IPO

Listing of Metropolis’s shares will provide a “stock currency” that can be used to fund acquisitions, managing director Shah said.


IHH tops TPG-backed consortium offer with $1.3b bid to buy India’s Fortis

Manipal’s revised plan offered Fortis shareholders 155 rupees per share, up from 140 rupees earlier.


South Africa’s Life Healthcare looking to sell its stake in India’s Max Healthcare

Life Healthcare is working with Barclays to explore potential interest in its 49.7% stake in Max Healthcare and could seek about $406 million for it.


India: Fortis in talks to raise capital as part of founders’ stake sale

The founders Singh brothers have been in talks with PE firms for the past year to sell their 34% stake in Fortis to pay down debt in their holding company.


Trends in Asian health-tech: Investors take note of an innovation demanding population

Increasingly affluent — and rapidly aging — populations are demanding better care and investors are becoming more adventurous.


M&A artist behind India’s best stock now faces his greatest test

When Dilip Shanghvi wants something, he has a track record of getting it.


Indian millionaire’s vaccine maker hunts for acquisitions

The chief executive officer of Asia’s largest vaccine maker is on a hunt for smaller rivals as he prepares for a bout of consolidation to hit the industry over the next few years.


Indian pharma player Claris said to start sale of $500m U.S. injectables unit

Shanghai Fosun Pharmaceutical Group Co. agreed last month to acquire 86 percent of Indian injectable-drug maker Gland Pharma Ltd. for as much as $1.26 billion. Pfizer Inc. bought Hospira Inc., the biggest maker of these medicines, in September for about $17 billion including debt.